Stone Ridge Asset Management’s Idexx Laboratories IDXX Stock Holding History

Stone Ridge Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,325	Closed	-$563K	–	678
2020 Q1	$563K	Sell	2,325 -3,800	-62%	-$992K	0.06%	350
2019 Q4	$1.6M	Hold	6,125	–	–	0.1%	259
2019 Q3	$1.67M	Hold	6,125	–	–	0.1%	249
2019 Q2	$1.69M	Sell	6,125 -100	-2%	-$24.6K	0.1%	248
2019 Q1	$1.39M	Buy	6,225 +313	+5%	+$64.6K	0.08%	311
2018 Q4	$1.1M	Buy	5,912 +2,447	+71%	+$502K	0.07%	371
2018 Q3	$865K	Buy	3,465 +100	+3%	+$24.3K	0.05%	554
2018 Q2	$733K	Buy	3,365 +284	+9%	+$58.5K	0.04%	588
2018 Q1	$590K	Hold	3,081	–	–	0.03%	687
2017 Q4	$482K	Buy	+3,081	New	+$485K	0.03%	826

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Stone Ridge Asset Management's IDXX Position: Q2 2020 in Review

Stone Ridge Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2020, closing a stake of 2,325 shares — an estimated $563K sold.

Stone Ridge Asset Management first reported a position in IDXX in Q4 2017 and held it in 10 quarters. The position peaked at $1.69M in Q2 2019. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

Stone Ridge Asset Management reported no remaining Idexx Laboratories position as of Q2 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 2,325 Idexx Laboratories shares in Q2 2020, an estimated $563K.
Stone Ridge Asset Management first reported a position in Idexx Laboratories in Q4 2017 and held it in 10 quarters.
Stone Ridge Asset Management's Idexx Laboratories position peaked at $1.69M in Q2 2019.
802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Stone Ridge Asset Management's 13F filing for Q2 2020, filed 23 Jul 2020.